Table 1 Patient demographics a
Age, yr | Tumor type (IDC, 1) (IDC/ILC, 1) (ILC, 0 ) | Nottingham score (out of 9) | Mitotic count/10 hpf | Triple-negative (+, 1) (−, 0) | HER2 (+, 1) (−, 0) | ER (+, 0) (−, 1) | Miller-Payne grade |
|---|---|---|---|---|---|---|---|
32 | 1 | 9 | 20 | 0 | 0 | 0 | 2 |
51 | 1 | 8 | 8 | 0 | 0 | 0 | 2 |
42 | 1 | 8 | 8 | 1 | 0 | 1 | 5 |
64 | 1 | 9 | 34 | 1 | 0 | 1 | 5 |
48 | 1 | 4 | 0 | 1 | 0 | 1 | 3 |
34 | 1 | 6 | 2 | 0 | 0 | 0 | 1 |
39 | 0 | 7 | 1 | 0 | 0 | 0 | 2 |
48 | 1 | 5 | 6 | 0 | 0 | 0 | 1 |
39 | 1 | 9 | 14 | 1 | 0 | 1 | 1 |
42 | 0 | 3 | 0 | 0 | 0 | 0 | 1 |
35 | 1 | 9 | 39 | 0 | 0 | 0 | 4 |
40 | 1 | 4 | 2 | 0 | 0 | 0 | 2 |
47 | 1 | 9 | 15 | 0 | 0 | 0 | 5 |
53 | 0 | 6 | 0 or 1 | 0 | 0 | 0 | 2 |
32 | 1 | 9 | 16 | 0 | 1 | 1 | 4 |
64 | 1 | 6 | 4 | 0 | 1 | 1 | 4 |
40 | 1 | 9 | 30 | 0 | 1 | 0 | 3 |
38 | 1 | 7 | 9 | 0 | 1 | 0 | 4 |
64 | 1 | 8 | 44 | 0 | 0 | 0 | 2 |
48 | 0 | 6 | 1 | 0 | 0 | 0 | 2 |
69 | 1 | 7 | 16 | 0 | 0 | 0 | 3 |
82 | 1 | 6 | 0 | 0 | 0 | 0 | 1 |
47b | 1 | 8 | 10 | 0 | 0 | 0 | 5 |
38 | 1 | 9 | 20 | 1 | 0 | 1 | 5 |
49 | 1 | 6 | 8 | 0 | 0 | 0 | 3 |
63b | 1 | 8 | 10 | 0 | 0 | 0 | 3 |
37 | 1 | 7 | 8 | 0 | 0 | 0 | 4 |
55 | 1 | 7 | 10 | 0 | 1 | 0 | 5 |
44 | 1 | 6 | 5 | 0 | 0 | 0 | 3 |
53 | 1 | 9 | 58 | 1 | 0 | 1 | 5 |
54 | 1 | 9 | 26 | 0 | 0 | 1 | 5 |
42 | 0 | 6 | 5 | 0 | 0 | 0 | 2 |
77 | 1 | 9 | 16 | 0 | 1 | 0 | 5 |
35 | 1 | 6 | 4 | 0 | 0 | 0 | 3 |